Ariane Business Updates

Papillon CXB Installed at St Barts Centre of Excellence

/in , , , /by

Expanding Access to Advanced Brachytherapy in London

We’re proud to announce the successful installation of the Papillon Contact X-ray Brachytherapy (CXB) system at the prestigious St Barts NHS Trust in London EC1 — marking a significant step forward in the delivery of specialist cancer care.

Located within the West Smithfield Trust, St Barts has now joined a growing network of centres across the UK and internationally offering advanced treatment using Papillon Brachytherapy technology, developed and manufactured by Ariane Medical Systems Ltd in the UK.

This cutting-edge solution provides highly targeted radiation therapy for early-stage rectal and skin cancers, delivering effective treatment with minimal side effects and preserving patient quality of life.

We are proud to support the dedicated clinical teams at St Barts in delivering world-class, patient-focused cancer care and look forward to the positive impact this installation will bring to patients in London and beyond.

To learn more about Papillon CXB and its clinical applications, contact us today.

June 2025

Ariane Event Updates

Ariane & Clerad Unite at SFCO 2025: Advancing Innovation in Breast Cancer Care

/in , , /by

Ariane Medical Systems and Clerad proudly came together for the first time to present a joint showcase at SFCO 2025 in Clermont-Ferrand, France, highlighting the latest in breast cancer treatment technology.

During the conference, we unveiled a powerful trio of innovations:

These cutting-edge technologies form a comprehensive approach to early-stage breast cancer care, enabling accurate detection, surgical margin confirmation, and targeted intra-operative radiotherapy — all designed to improve patient outcomes and streamline the treatment process.

This collaboration demonstrates our shared commitment to advancing cancer care through innovation and integration. We’re excited to continue these conversations and share more developments in the months ahead.

Want to learn more or arrange a demonstration? Contact our team today.

May 2025

A Successful ESRTO 2025 for Ariane Medical – Global Interest Grows in Pallion+

/in , , /by

Following key announcements on our latest technical developments and innovations in radiotherapy, Ariane Medical Systems had an incredibly successful showing at ESRTO 2025.

The event served as a powerful platform to showcase the capabilities of our Pallion+ system, with overwhelmingly positive feedback from clinicians, researchers, and healthcare professionals across the globe. Our presence generated significant interest — and we are now actively following up on a large number of product enquiries from across Europe, the Gulf States, the United States, and beyond.

This strong international response reflects growing recognition of Ariane Medical’s commitment to innovation, clinical precision, and patient-first technology in the radiotherapy space.

As we continue to build on the momentum of ESRTO 2025, we look forward to further collaborations and partnerships that will help bring Pallion+ into more treatment centres worldwide.

📩 For product enquiries or more information, please contact our team

May 2025